Trials / Conditions / Head and Neck Cancer Metastatic
Head and Neck Cancer Metastatic
6 registered clinical trials studyying Head and Neck Cancer Metastatic — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers NCT05582590 | NexImmune Inc. | Phase 1 |
| Recruiting | Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Pr NCT06678724 | National Taiwan University Hospital | — |
| Completed | Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer NCT03993353 | University of California, San Diego | Phase 2 |
| Completed | Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHN NCT03878979 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Terminated | A Study of ADXS-NEO Expressing Personalized Tumor Antigens NCT03265080 | Advaxis, Inc. | Phase 1 |
| Active Not Recruiting | Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck NCT02474368 | Dana-Farber Cancer Institute | Phase 1 |